default author photo

Elizabeth Jacobi

Houston Methodist Hospital

6621 Fannin St

Houston, TX 77030

United States

SCHOLARLY PAPERS

1

DOWNLOADS

34

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

B72.3 Serves as a New Diagnostic Marker for Testicular Leydig Cell Tumor

Number of pages: 20 Posted: 01 Dec 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, Houston Methodist Hospital and University of Texas at Houston - MD Anderson Cancer Center
Downloads 34 (1,263,436)

Abstract:

Loading...

Leydig cell tumor, Sertoli cell tumor, testis, B72.3, biomarker